Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
1,991 recalls · newest first
cGMP deviations
Failed Stability Specifications: Observed OOS results: eg results for colour index
Defective container: cracked/broken cartridges
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj.
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj.
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
Lack of Assurance of Sterility: Potential for flexible container leaks.
Failed stability specifications: Out of specification for hardness test
Failed stability specifications: Out of specification for hardness test
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate…
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…